The potential market for the drugs is massive — more than 40 percent of adults in the U.S. are obese — and has seen explosive ...
An obesity medicine physician writes that weight-loss drugs such as Ozempic have been getting a bad rap, almost as if those ...
This study provides valuable insight into the increasing use of obesity drugs. The rising prescription numbers suggest that ...
The General Pharmaceutical Council (GPhC) have published the new guidance for prescribing weight loss injections such as ...
GPs could be at medico-legal risk if they ignore requests from online pharmacies for patient information for prescribing ...
While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.
Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.
Hosted on MSN9d
More prescriptions for diabetes drug in BuckinghamshireMore prescriptions were handed out for semaglutide – a drug used to treat diabetes – in Buckinghamshire last year, figures ...
More prescriptions were handed out for semaglutide – a drug used to treat diabetes – in east Berkshire, north east Hampshire, ...
Pharmacy regulator warns some people with history of eating disorders wrongly obtaining medicines such as Wegovy or Mounjaro ...
Online pharmacies will now have to employ stricter checks to stop people who are already a healthy weight or have a history ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results